Gene study aims to make Post-Surgery painkillers safer

NCT ID NCT06996561

First seen Apr 16, 2026 · Last updated Jun 12, 2026 · Updated 13 times

Summary

This study looks at whether a person's genetic makeup influences how well the painkiller nalbuphine works after abdominal or pelvic surgery. Researchers will collect blood samples from 263 adults before and after surgery to analyze genes linked to pain relief. The goal is to improve pain management and reduce the risk of opioid-related problems in the Pakistani population.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ziauddin University

    RECRUITING

    Karachi, Sindh, 755000, Pakistan

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.